ProStrakan Secures Offer From Japan's Kyowa Hakko, But Analysts Say Too Low

 
• By The Pink Sheet Daily

Kyowa Hakko Kirin's offer to buy U.K.-based specialty pharma ProStrakan values the company lower than other similar deals.

More from Japan

More from Asia